Biortus Offers Critical Proteins of SARS-CoV-2

Joining global efforts to fight SARS-CoV-2, Biortus is offering several products and services to both scientific and industrial communities to assist researchers in finding effective treatments agains

15

2020

/

05

About Biortus

Biortus is an innovation driven contract research organisation (CRO) committed to high quality R&D services in support of drug discovery.

11

2020

/

05

Biortus Participating in the Mechanistic Study of Remdesivir and Co-authoring the Science Article

As a CRO company, Biortus often contributes to drug discovery work behind the scenes. As an innovative company, Biortus also appears in high quality scientific articles from time to time. This time, B

04

2020

/

05

Biortus Successfully Enters the “List of R&D Enterprises in Jiangsu Province Cultivated in 2019”

With the sound of the New Year’s bell still ringing, Biortus welcomes the exciting news from the Department of Science and Technology at Jiangsu Province. In the Department’s first launched R&D Enterp

07

2020

/

01

Expertise from Biortus contributes in the new Science article

In the newly published Science article “Cryo-EM Structures of the Human Cation-Chloride Cotransporter KCC1”, research teams revealed the structure of human potassium chloride co-transporter KCC1, base

04

2019

/

11

Biortus and XtalPi Announce Strategic Partnership

Wuxi Biortus Biosciences Co., Ltd. (Biortus) and Shenzhen XtalPi Technology Co., Ltd. (XtalPi) reached a strategic partnership agreement on August 26, 2019.

28

2019

/

08

< 123 >